Ascletis

Ascletis is a Hangzhou, Zhejiang-based biotechnology and pharmaceutical company that is relevant as a corporate strategic investor for life sciences fundraises. Its investment relevance is tied to biotechnology, pharmaceuticals and oncology, with participation in U.S. biotechnology financings. The company is listed on the Hong Kong Stock Exchange and develops therapeutics including metabolic-disease programs, making it most relevant for founders seeking strategic life sciences capital rather than a traditional venture fund.